Sumatriptan Injection, Solution
Product Images NDC 83270-152

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 83270-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Onesource Specialty Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Autoinjector-carton (Auto Injector Carton)

Packaging label for Sumatriptan Injection USP 6 mg/0.5 mL autoinjector system by OneSource Specialty Pharma. The label indicates the product is for subcutaneous injection only and includes two prefilled autoinjector syringes containing 6 mg sumatriptan each. The label also provides instructions for use and regulatory information.*

FDA Label Image

Image Description (Image 1)

Chemical structure diagram of the active ingredient sumatriptan, showing its molecular composition and arrangement of atoms.*

FDA Label Image

Figure D (Image 10)

An instructional illustration showing how to remove the cap from a sumatriptan subcutaneous injection pen by pulling the cap straight off. The image depicts hands holding the pen and the cap, with arrows indicating the direction to pull.*

FDA Label Image

Figure E (Image 11)

An instructional figure labeled as Figure E demonstrating correct and incorrect positioning of a gray and white injection device component. The left side shows the correct orientation marked with a green check, and the right side shows the incorrect orientation marked with a red X.*

FDA Label Image

Figure F (Image 12)

Instructional image demonstrating the correct use of a subcutaneous injection. The hand grips the injection device perpendicular (90 degrees) to the skin. An arrow points downward with text instructing to press down against the skin to unlock the device.*

FDA Label Image

Figure G (Image 13)

An instructional illustration showing a hand pressing down on a sumatriptan subcutaneous injection device, indicated by a 'press' arrow and a 'click' sound bubble, with the needle inserted into a person's skin. This demonstrates the proper technique for administering the injection.*

FDA Label Image

Figure H (Image 14)

An instructional illustration showing the injection of sumatriptan solution subcutaneously. The image depicts a hand holding the autoinjector pressed against the skin, with an inset indicating that the blue plunger moves down to completely fill medicine flow after injection.*

FDA Label Image

Figure I (Image 15)

An instructional diagram labeled Figure I showing a hand holding a subcutaneous injection device at a patient's skin surface. The image includes text instructing to wait 5 seconds before lifting the device up, indicating part of the injection process for sumatriptan injection solution.*

FDA Label Image

Figure J (Image 16)

An instructional illustration showing a hand holding a sumatriptan autoinjector positioned for subcutaneous injection into the skin. The image includes a prompt to remove the autoinjector from the skin after administration.*

FDA Label Image

Figure K (Image 17)

An illustration labeled Figure K showing a red biohazard sharps container with a warning label on the front. The container has an opening on the top for the disposal of needles or syringes.*

FDA Label Image

Figure 1 (Image 2)

Line graph depicting the estimated percentage of patients experiencing relief over time in minutes, comparing sumatriptan and placebo treatments. The graph shows two lines: one for placebo (N=127) and one for sumatriptan (N=131), with sumatriptan resulting in a higher percentage of patients with relief at each time point up to 25 minutes.*

FDA Label Image

Image Description (Image 6)

Illustration of a sumatriptan subcutaneous injection autoinjector showing labeled parts including the gray cap which must be removed for use, the medicine window to check that the liquid is clear, and the blue injection button that must be pressed firmly to start the injection.*

FDA Label Image

Figure A (Image 7)

An instructional diagram showing two methods of subcutaneous injection site administration for sumatriptan injection solution. One image demonstrates injection into the thigh, and the other shows injection into the arm, each with a person holding a syringe to the respective site.*

FDA Label Image

Figure B (Image 8)

Illustration labeled Figure B showing a subcutaneous injection device before use, with a clear liquid visible inside the syringe. The image highlights the presence of the clear liquid prior to injection.*

FDA Label Image

Figure C (Image 9)

An instructional diagram labeled 'Figure C' illustrating the status of a subcutaneous injection device after injection. The image shows the device with a blue plunger rod filling the window, demonstrating that the injection has been completed.*

FDA Label Image

Ifu-prefilled-syringe (Instruction For Use Prefilled Syringe)

Instructions for use of Sumatriptan Injection, USP prefilled syringes with BD UltraSafe Plus Passive Needle Guard system. The illustrated guide details system components, preparation steps including hand washing and site selection, injection technique with needle insertion into pinched skin, post-injection actions, and proper needle disposal. Photographs and labeled syringe diagrams accompany the instructions. Manufacturer and distributor information is provided at the bottom.*

FDA Label Image

Autoinjector-label (Auto Injector Label)

Sumatriptan Injection USP 6 mg/0.5 mL autoinjector system for subcutaneous injection only. The label indicates a single-dose autoinjector containing 0.5 mL solution with 6 mg sumatriptan. Manufactured by Onesource Specialty Pharma Limited, distributed by Stribdes Pharma Inc. Storage and handling instructions are included.*

FDA Label Image

Device Image (Image 5)

Sumatriptan injection USP 6 mg/0.5 mL subcutaneous autoinjector by ONESOURCE SPECIALTY PHARMA LIMITED. The image shows a single-dose liquid-filled autoinjector designed for subcutaneous administration. The label indicates a 0.5 mL volume, 6 mg sumatriptan strength, and usage information for acute migraine treatment.*

FDA Label Image

Pfs Carton (Prefilled Syringe Carton Label)

Packaging label for Sumatriptan Injection, USP, 6 mg per 0.5 mL in solution form for subcutaneous injection. The label specifies a carton containing two 0.5 mL single-dose prefilled syringes. The labeler is OneSource Specialty Pharma Limited, with distribution by Strides Pharma Inc. Dosage and storage information is included in small print.*

FDA Label Image

Pfs Foil Label (Prefilled Syringe Foil Label)

Label for Sumatriptan Injection, USP 6 mg per 0.5 mL single-dose prefilled syringe by Onesource Specialty Pharma Limited. The label states it is for subcutaneous injection only and includes storage instructions and manufacturing details, along with NDC 83270-152-01.*

FDA Label Image

Pfs Label (Prefilled Syringe Label)

Label for Sumatriptan Injection, USP, 6 mg per 0.5 mL, a subcutaneous injection by Onesource Specialty Pharma Limited. Features dosage strength and volume, NDC 83270-152-01, barcode, manufacturing and distribution information, and indications for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.